Complejo Hospitalario Universitario de Lugo
Centro asistencial
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (38)
2023
-
Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 247-262
-
Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage
Frontiers in Cellular Neuroscience, Vol. 16
-
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81
2021
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
-
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
Journal of Clinical Endocrinology and Metabolism, Vol. 106, Núm. 2, pp. E660-E674
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
-
PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: A pairwise meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-13
-
Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
BMC Rheumatology, Vol. 4, Núm. 1
2019
-
Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Clinical Reviews in Allergy and Immunology, Vol. 56, Núm. 3, pp. 278-292
2018
-
Inflammatory arthritis and heart disease
Current Pharmaceutical Design, Vol. 24, Núm. 3, pp. 262-280
-
Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach
International Journal of COPD, Vol. 13, pp. 591-601
2017
-
Asthma-COPD overlap is not a homogeneous disorder: Further supporting data
Respiratory Research
-
Quality indicators of asthma care derived from the spanish guidelines for asthma management (GEMA 4.0): A multidisciplinary team report
Journal of Investigational Allergology and Clinical Immunology
2016
-
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
Journal of Neuro-Oncology, Vol. 127, Núm. 3, pp. 569-579
-
Validation of the international metastatic renal-cell carcinoma database consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: The Spanish oncologic genitourinary group (SOGUG) SPAZO study
Annals of Oncology, Vol. 27, Núm. 4, pp. 706-711
2014
-
Endoscopic submucosal dissection
Endoscopy, Vol. 46, Núm. 4, pp. 361-370